Robyn Broad

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

David S. Hong, Brian A. Van Tine, Swethajit Biswas et al. · Nature Medicine · 2023 · 171 citations · Full text

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10⁺ advanced non-small cell lung cancer

George R. Blumenschein, Siddhartha Devarakonda, Melissa L. Johnson et al. · Journal for ImmunoTherapy of Cancer · 2022 · 48 citations · Full text

Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy

Robyn Broad, Stacey Jones, Melina C. Teske et al. · British Journal of Cancer · 2021 · 44 citations · Full text

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

David S. Hong, Marcus O. Butler, Russell K. Pachynski et al. · Frontiers in Oncology · 2022 · 19 citations · Full text

Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients

Tianjiao Wang, Jean-Marc Navenot, Stavros Rafail et al. · Molecular Therapy — Methods & Clinical Development · 2024 · 15 citations · Full text